Estimating relative potency for receptor-mediated toxicity: Reevaluating the toxicity equivalence factor (TEF) model

被引:42
作者
Putzrath, RM
机构
[1] Georgetown Risk Group, Washington, DC 20007, 3223 N Street, NW
关键词
D O I
10.1006/rtph.1996.1063
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Once considered an interim procedure for use with mixtures of polychlorinated dibenzo-p-dioxins and dibenzofurans, use of the toxicity equivalence factor (TEF) model has been proposed for other groups of structurally similar chemicals. Data from polychlorinated dibenzo p-dioxins and polychlorinated dibenzofurans as web as theoretical analyses of the biological basis for receptor-mediated toxicity demonstrate the limitations of this model and indicate that estimation of equivalent doses for such chemicals is more likely to require a function than a point estimate such as a TEF. Relatively small changes in the TEFs can result in both significant changes in the estimated dose for the mixture and the percentage of the estimated risk that is attributable to the most potent or reference compound. Estimates of equivalent doses are likely to become less accurate when extrapolated to lower responses which frequently serve as the basis for regulatory decisions. Existing models allow the relative potency to be a function rather than a point estimate as well as interaction at the receptor among the chemicals. (C) 1997 Academic Press.
引用
收藏
页码:68 / 78
页数:11
相关论文
共 45 条
  • [1] *AG TOX SUBST DIS, 1989, ATSDRTP8823
  • [2] TOXIC EQUIVALENCY FACTORS FOR DIOXIN-LIKE PCBS - REPORT ON A WHO-ECEH AND IPCS CONSULTATION, DECEMBER 1993
    AHLBORG, UG
    BECKING, GC
    BIRNBAUM, LS
    BROUWER, A
    DERKS, HJGM
    FEELEY, M
    GOLOR, G
    HANBERG, A
    LARSEN, JC
    LIEM, AKD
    SAFE, SH
    SCHLATTER, C
    WAERN, F
    YOUNES, M
    YRJANHEIKKI, E
    [J]. CHEMOSPHERE, 1994, 28 (06) : 1049 - 1067
  • [3] MODELING OF THE PHARMACODYNAMIC INTERACTION OF AN A(1) ADENOSINE RECEPTOR AGONIST AND ANTAGONIST IN-VIVO - N-6-CYCLOPENTYLADENOSINE AND 8-CYCLOPENTYLTHEOPHYLLINE
    APPEL, S
    MATHOT, RAA
    LANGEMIJER, MWE
    IJZERMAN, AP
    DANHOF, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (07) : 1253 - 1259
  • [5] Use of toxic equivalency factors for risk assessment for dioxins and related compounds
    Birnbaum, LS
    DeVito, MJ
    [J]. TOXICOLOGY, 1995, 105 (2-3) : 391 - 401
  • [6] TERATOGENIC EFFECTS OF POLYCHLORINATED DIBENZOFURANS IN COMBINATION IN C57BL/6N MICE
    BIRNBAUM, LS
    HARRIS, MW
    CRAWFORD, DD
    MORRISSEY, RE
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 91 (02) : 246 - 255
  • [7] BRADFIELD CA, 1988, MOL PHARMACOL, V34, P682
  • [8] CLEVENGER MA, 1991, RISK ANAL PROSPECTS, P293
  • [9] A NEW METHOD FOR DETERMINING ALLOWABLE DAILY INTAKES
    CRUMP, KS
    [J]. FUNDAMENTAL AND APPLIED TOXICOLOGY, 1984, 4 (05): : 854 - 871
  • [10] DOSE-RESPONSE RELATIONSHIPS IN MICE FOLLOWING SUBCHRONIC EXPOSURE TO 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN - CYP1A1, CYP1A2, ESTROGEN-RECEPTOR, AND PROTEIN-TYROSINE PHOSPHORYLATION
    DEVITO, MJ
    MA, XF
    BABISH, JG
    MENACHE, M
    BIRNBAUM, LS
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 124 (01) : 82 - 90